Evidence map›Paper›PMID 40942277›Full record

ArticlePolymers2025

Discovery and Development of One Monomer Molecularly Imprinted Polymers (OMNiMIPs).

Danielle S Meador, Stephanie S Houck, David A Spivak

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danielle S MeadorDepartment of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA.
Stephanie S HouckParkersburg High School, 2101 Dudley Ave, Parkersburg, WV 26101, USA.
David A SpivakDepartment of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA.ORCID 0000-0002-0527-222X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecularly imprinted polymers (MIPs) are polymeric receptors for a targeted template molecule that are traditionally formed using a combination of functional monomers and crosslinkers. While investigating novel crosslinkers for MIPs, one of these (2-(methacryloylamino)ethyl-2-methylacrylate (referred to as N,O-bismethacryloyl ethanolamine or "NOBE")) performed better when used alone versus in combination with other monomers. This introduced the concept of one monomer molecularly imprinted polymers, given the acronym OMNiMIPs, and prompted studies provided in this report that clarify OMNiMIPs have fundamental differences compared to traditionally formulated MIPs. Enantioselectivity studies using BOC-L-tyrosine as a standard template showed that NOBE OMNiMIPs afforded higher-performing MIPs compared with traditional MIPs, have significantly higher binding capacities, and have an internal hydrogen-bonded crosslinking structure that contributes to the morphological stability of the binding site structure. Based on the adventitious discovery of NOBE OMNiMIPs, new analogs based on the NOBE structure were developed and evaluated for further enhancement of molecular recognition performance and novel capabilities of OMNiMIPs. While the majority of the new OMNiMIPs exhibited enantiomeric selectivity toward BOC-L-tyr, improvements were not observed compared with NOBE.

Indexed as

artificial receptorcrosslinkerCSPenantioselectiveMIPmolecular imprintingmolecular recognitionOMNiMIP

Identifiers

PMID40942277
PMCPMC12430952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.